Gland Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BSE:543245 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
27 Jun 24	Sell₹5,356,339	S. Rao	Individual	2,950	₹1,822.39
27 Jun 24	Sell₹7,180,127	P. Varma	Individual	3,950	₹1,825.31
27 Jun 24	Sell₹2,531,000	Bh Raja	Individual	1,400	₹1,807.86
27 Jun 24	Sell₹21,618,039	Rong Wu	Individual	11,974	₹1,820.65
25 Jun 24	Sell₹4,100,501	T. Satyanarayana	Individual	2,250	₹1,822.44
25 Jun 24	Sell₹5,472,000	Bh Raja	Individual	3,000	₹1,824.00
24 Jun 24	Sell₹2,737,500	K Rao	Individual	1,500	₹1,825.00
24 Jun 24	Sell₹1,825,000	S. Rao	Individual	1,000	₹1,825.00
24 Jun 24	Sell₹7,300,000	P. Varma	Individual	4,000	₹1,825.00
24 Jun 24	Sell₹1,766,600	A. Jayatheertha	Individual	968	₹1,825.00
24 Jun 24	Sell₹908,528	Prakash Baliga	Individual	500	₹1,817.06
20 Jun 24	Sell₹17,540,947,848	Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	Company	9,900,000	₹1,771.81
20 Jun 24	Sell₹23,729,390	Prakash Baliga	Individual	13,000	₹1,825.34
10 Jun 24	Sell₹8,305,098	K Rao	Individual	4,456	₹1,890.00
03 Jun 24	Sell₹1,850,250	K Rao	Individual	1,000	₹1,850.25
31 May 24	Sell₹9,199,750	M. Ravichandra	Individual	5,000	₹1,840.15
30 May 24	Sell₹9,186,249	C. Venkatesan	Individual	5,000	₹1,837.25
21 Mar 24	Sell₹4,463,085	C. Jyothirlatha	Individual	2,540	₹1,757.12
18 Mar 24	Sell₹1,250,599	P. Balaji	Individual	700	₹1,786.57
15 Mar 24	Sell₹14,313,196	K. Raju	Individual	7,992	₹1,790.94
15 Mar 24	Sell₹1,763,610	P. Balaji	Individual	1,000	₹1,781.01
12 Mar 24	Sell₹8,650,000	M. Ravichandra	Individual	5,000	₹1,730.00
23 Feb 24	Sell₹2,813,119	Prakash Baliga	Individual	1,525	₹1,844.67

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 543245?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	10	0.00000607%
Individual Insiders	10,651	0.00646%
General Public	14,946,118	9.07%
Institutions	58,232,534	35.3%
Private Companies	91,562,410	55.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 90.71% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
51.8%	Fosun Pharma Industrial Pte Ltd.	85,393,894	₹141.7b	0%	no data
7.61%	Mirae Asset Global Investments Co., Ltd.	12,545,772	₹20.8b	11.2%	0.21%
6.4%	HDFC Asset Management Company Limited	10,541,992	₹17.5b	3.68%	0.38%
6.32%	Nippon Life India Asset Management Limited	10,411,689	₹17.3b	-0.24%	0.47%
4.76%	ICICI Prudential Asset Management Company Limited	7,844,783	₹13.0b	49.9%	0.24%
3.74%	RP Advisory Services Private Limited	6,166,486	₹10.2b	0%	no data
3.18%	SBI Funds Management Limited	5,244,161	₹8.7b	-3.6%	0.11%
1.37%	Aditya Birla Sun Life AMC Limited	2,263,230	₹3.8b	-19.4%	0.22%
1.28%	UTI Asset Management Company Limited	2,114,300	₹3.5b	-13%	0.14%
0.86%	Norges Bank Investment Management	1,420,358	₹2.4b	0%	no data
0.6%	Goldman Sachs Asset Management, L.P.	992,340	₹1.6b	-0.01%	no data
0.5%	DSP BlackRock Investment Managers Pvt. Ltd.	822,541	₹1.4b	131%	0.12%
0.44%	Invesco Ltd.	719,117	₹1.2b	0%	no data
0.35%	BlackRock, Inc.	575,517	₹954.9m	-0.91%	no data
0.35%	Bandhan AMC Limited	571,818	₹948.8m	-32.1%	0.15%
0.21%	PineBridge Investments LLC	339,486	₹563.3m	-0.19%	0.03%
0.2%	Eastspring Investments (Singapore) Limited	323,436	₹536.7m	0%	0.02%
0.17%	Tata Asset Management Limited	281,815	₹467.6m	1.25%	0.05%
0.16%	DSP Asset Managers Pvt. Ltd	266,053	₹441.4m	38.1%	0.75%
0.075%	quant Money Managers Ltd.	124,235	₹206.1m	0%	0.02%
0.07%	Mahindra Manulife Investment Management Pvt. Ltd.	115,000	₹190.8m	27.8%	0.08%
0.069%	BNY Asset Management	113,350	₹188.1m	0.17%	no data
0.064%	Danske Capital Denmark	105,878	₹175.7m	0%	0.01%
0.059%	Dimensional Fund Advisors LP	97,135	₹161.2m	45.4%	no data
0.035%	Motilal Oswal Asset Management Company Limited	58,450	₹97.0m	8.82%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/21 21:25
End of Day Share Price	2025/01/21 00:00
Earnings	2024/09/30
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Gland Pharma Limited is covered by 22 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Prashant Nair	Ambit Capital
Nitin Bhasin	Ambit Capital
Neha Manpuria	BofA Global Research